干细胞诊所, 巴塞罗那, 西班牙

地址: 扩展区, 08025 巴塞罗那, 西班牙联系方式: spain@nbscience.com: +447778936902 , +33745637397, +34670491885 干细胞已经被用于: 部分乳房切除术或肿瘤切除术后的乳房重建. Also in combination with lipotransferring for breast augmentation Tissue regeneration after irradiation necrosis Calvarial repair after injury Fistula healing:  气管 (组织坏死), 肛周和克罗恩病 阅读更多…

The Safety/Efficacy of hUC Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis

The Safety/Efficacy of hUC Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis This is a random, open label, and parallel controled experiment. All patients are selected and sign consent forms, then divided into 3 groups. Doctors collect the basic information of patient. All patients receive laboratory and image examination as 阅读更多…

hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis

hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis Cirrhosishepatitis Cirrhosis Detailed Description: This experimental use umbilical cord mesenchymal stem cells in treatment of decompensated hepatitis B cirrhosis to evaluate its safety and efficacy, This experimental is mainly aimed at people aged 18-60 years old, regardless of gender 阅读更多…

Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (间充质干细胞) in Multiple Sclerosis (多发性硬化症) with progressive disease status.

Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells

Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells Brief Summary:The purpose of this study is to investigate the potential use of Wharton’s Jelly Mesenchymal stem cells (WJ-MSCs) for treatment of patient diagnosed with Corona Virus SARS-CoV-2 infection, and showing symptoms of COVID-19. Condition or disease Intervention/treatment Phase Use of Stem Cells for 阅读更多…

COVID-19 and stem cells therapy

Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors https://doi.org/10.1186/s13287-019-1156-6 Abstract Background Immunoregulatory capacity of mesenchymal stem cells (MSC) is triggered by the inflammatory environment, which changes during tissue repair. Macrophages are essential in mediating the inflammatory response after injury and can adopt a range of functional 阅读更多…

干细胞疗法